Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-109,999
Closed -$388K 140
2016
Q3
$388K Hold
109,999
﹤0.01% 129
2016
Q2
$1.47M Hold
109,999
0.02% 106
2016
Q1
$1.77M Hold
109,999
0.02% 105
2015
Q4
$1.75M Sell
109,999
-109,999
-50% -$1.89M 0.01% 111
2015
Q3
$3.13M Hold
219,998
0.03% 89
2015
Q2
$4.91M Hold
219,998
0.04% 80
2015
Q1
$4.45M Sell
219,998
-5,002
-2% -$93.1K 0.04% 77
2014
Q4
$3.7M Hold
225,000
0.04% 82
2014
Q3
$3.43M Hold
225,000
0.04% 76
2014
Q2
$5.64M Hold
225,000
0.07% 65
2014
Q1
$4.71M Buy
+225,000
New +$7.98M 0.06% 76
2013
Q3
Sell
-166,667
Closed -$2M 86
2013
Q2
$2M Buy
+166,667
New +$2.46M 0.04% 63

Other funds holding CYTR

Julian Baker's CYTR Position: Q4 2016 in Review

Julian Baker sold out of CytRx Corp (CYTR) in Q4 2016, closing a stake of 109,999 shares — an estimated $388K sold.

Julian Baker first reported a position in CYTR in Q2 2013 and held it in 12 quarters. The position peaked at $5.64M in Q2 2014. 73 funds tracked by Wall St. Rank hold CYTR as of Q4 2016.

  • Julian Baker reported no remaining CytRx Corp position as of Q4 2016 after selling out during the quarter.
  • Julian Baker sold 109,999 CytRx Corp shares in Q4 2016, an estimated $388K.
  • Julian Baker first reported a position in CytRx Corp in Q2 2013 and held it in 12 quarters.
  • Julian Baker's CytRx Corp position peaked at $5.64M in Q2 2014.
  • 73 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2016.

Based on Baker Bros. Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.